85 results on '"Lobello, S"'
Search Results
2. O6.3HIGH EDUCATIONAL LEVELS AS PROTECTIVE FACTOR AGAINST DRUG AND ALCOHOL CONSUMPTION
3. O4.2HARMFUL ALCOHOL CONSUMPTION IN HEALTH-WORKERS: RESULTS OF A SCREENING STUDY
4. DAILY INTERFERON MONOTHERAPY VERSUS DAILY INTERFERON PLUS AMANTADINE IN THE TREATMENT OF NAIVE CHRONIC HEPATITIS C PATIENTS: SHORT-TERM RESPONSE
5. ASYMPTOMATIC HCV CARRIERS: ARE INFECTION RISK FACTORS, HCV GENOTYPES, DEMOGRAPHIC CHARACTERISTICS, OTHER HEPATOTOXIC AGENTS AFFECTING THE CLINICAL OUTCOME?
6. Colchicine in chronic hepatitis B: a pilot study
7. Interferon treatment in hepatitis B surface antigen-positive hepatitis B e antibody-positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring
8. Impact of HBV infection in HCV/HBV coinfected patients treated with DAAs IN Northern Italy
9. P.04.1 BURDEN OF ALCOHOLIC LIVER DISEASE (ALD) ON HOSPITAL ADMISSION IN THE VENETO REGION (NORTHEAST ITALY). A RETROSPECTIVE STUDY BASED ON A LARGE DATABASE
10. Efficacy and safety of Elbasvir/Grazoprevir in a large real-life cohort of HCV-infected patients
11. THU-083 - Hospitality discharge for alcohol related problems in north east Italy in a sixteen-years period: Influence of new population at risk
12. P.09.8 HOSPITALITY DISCHARGE FOR ALCOHOL-RELATED PROBLEMS IN NORTH EAST ITALY IN A SIXTEEN-YEARS PERIOD: INFLUENCE OF NEW POPULATION AT RISK
13. OC.04.6 FROM ALFA-INTERFERON TO DAAS: IMPACT ON HOSPITALIZATION RATE FOR HCV LIVER RELATED DISEASES FROM 2000 TO 2016 IN NORTH EST ITALY
14. Effectiveness and safety of DAA treatment for recurrent hepatitis C after liver transplantation: The NAVIGATOR Lombardia-Veneto network
15. Right timing for transient elastography lead the right follow up after HCV treatment
16. Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study Group
17. Hepatitis B virus screening in healthy immigrants: A strategy to prevent the spread of infection and to identify and manage chronic hepatitis B (CHB)
18. Hepatitis C virus in healthy immigrants: To screen or not to screen?
19. A cost-consequence analysis of screening and treatment for chronic hepatitis B (CHB) virus infection in resident immigrants of an Italian North-East
20. P.18.1 A PROPER ORGANIZATIONAL MODEL ENCOURAGES HIGH RATE OF INTENTION-TO-TREAT SUSTAINED VIROLOGICAL RESPONSE IN AN INJECTING DRUG USERS HCV+ POPULATION
21. P.03.18 NAFLD/NASH: MUCH ADO ABOUT NOTHING? A 25 YRS RETROSPECTIVE STUDY IN A COHORT OF DIABETIC PATIENTS
22. OC8 SCREENING FOR HBV IN IMMIGRANTS: PILOT PHASE OF EPIDEMIOLOGICAL STUDY IN HEALTY POPULATION
23. F-49 A randomized multicentre double-blind vs placebo trial: Evaluation of effect of silybin conjugated with phosphatidilcholine and vitamin E on liver damage in patients with nonalcoholic fatty liver disease
24. In Television Land...'Whiz Kids' Makes Hacking Fun
25. People Shaping Educational Computing: Irwin Hoffman
26. People Shaping Educational Computing: Seymour Papert
27. People Shaping Educational Computing: Dorothy Deringr
28. People Shaping Educational Computing: Sherwin Steffin
29. People Shaping Educational Computing: Jessie Muse
30. Robots: The Next Educational Challenge?
31. High-fat diet and the risk for non-alcoholic fatty liver disease: A population-based study
32. PO.15 PREVENTION AND EARLY DIAGNOSIS OF COLORECTAL CANCER WITH ENDOSCOPY: WHAT IS USEFUL?
33. PA.87 ALCOHOL-RELATED PROBLEMS IN HEALTH-WORKERS IN A GENERAL HOSPITAL: A SCREENING STUDY
34. Multidisciplinary intervention for management of alcohol-related problems: Results of a thirthy-months experience
35. Binge drinking, alcohol abuse and dependence: Screening study in an emergency department
36. Harmful alcohol consumption in health-workers: Results of a screening study
37. Gallstones and liver steatosis do not share the same risk factors: Results of the “Arsita 1” open population survey
38. Emergent Endotracheal Intubation and Mortality in Traumatic Brain Injury
39. Long-term follow-up of HBeAg minus chronic hepatitis patients treated with interferon during the peak of anti-HBcIgM
40. Preliminary results of a two-center trial with colchicine for the treatment of chronic Hepatitis B
41. Sustained response to 12-month interferon treatment in patients with chronic hepatitis C: A comparison between different IFN doses
42. Daily interferon monotherapy versus daily interferon plus amantadine in the treatment of naive chronic hepatitis C: End of treatment response
43. 982 BINGE DRINKING, ALCOHOL ABUSE AND DEPENDENCE: SCREENING STUDY IN AN EMERGENCY DEPARTMENT.
44. 1008 HIGH-FAT DIET AND THE RISK FOR NON-ALCOHOLIC FATTY LIVER DISEASE: A POPULATION BASED-STUDY
45. Household contacts enhance the community risk factors of HCV transmission: A seroepidemiological study in the same open population
46. LP52 : Nonalcoholic fatty liver disease (NAFLD) as potential risk factor of cardiovascular disease and oncological disease in diabetic type 2 patients.
47. P1282 A COST–CONSEQUENCE ANALYSIS OF SCREENING AND TREATMENT FOR CHRONIC HEPATITIS B (CHB) VIRUS INFECTION IN RESIDENT IMMIGRANTS OF AN ITALIAN NORTH-EAST REGION.
48. 1280 NAFLD/NASH: MUCH ADO ABOUT NOTHING? A 25 YRS RETROSPECTIVE STUDY IN A COHORT OF DIABETIC PATIENTS
49. 825 SILYBIN CONJUGATED WITH PHOSPHATIDYLCHOLINE AND VITAMIN E IMPROVES LIVER DAMAGE IN PATIENTS WITH NAFLD: THE RESULTS OF A RANDOMIZED MULTICENTRE DOUBLE-BLIND VS PLACEBO TRIAL
50. Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.